Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1

The tumor microenviroment can influence cancer progression and response to therapy. In this study, the authors show that miR21 is transferred through exosomes from cancer-associated fibroblasts and adipocytes to ovarian cancer cells where it modulates drug resistance by its direct target APAF1.

Guardado en:
Detalles Bibliográficos
Autores principales: Chi Lam Au Yeung, Ngai-Na Co, Tetsushi Tsuruga, Tsz-Lun Yeung, Suet-Ying Kwan, Cecilia S. Leung, Yong Li, Edward S. Lu, Kenny Kwan, Kwong-Kwok Wong, Rosemarie Schmandt, Karen H. Lu, Samuel C. Mok
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2016
Materias:
Q
Acceso en línea:https://doaj.org/article/ff39043eef974cb8bf3b0f0a415eb6b1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ff39043eef974cb8bf3b0f0a415eb6b1
record_format dspace
spelling oai:doaj.org-article:ff39043eef974cb8bf3b0f0a415eb6b12021-12-02T15:34:55ZExosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF110.1038/ncomms111502041-1723https://doaj.org/article/ff39043eef974cb8bf3b0f0a415eb6b12016-03-01T00:00:00Zhttps://doi.org/10.1038/ncomms11150https://doaj.org/toc/2041-1723The tumor microenviroment can influence cancer progression and response to therapy. In this study, the authors show that miR21 is transferred through exosomes from cancer-associated fibroblasts and adipocytes to ovarian cancer cells where it modulates drug resistance by its direct target APAF1.Chi Lam Au YeungNgai-Na CoTetsushi TsurugaTsz-Lun YeungSuet-Ying KwanCecilia S. LeungYong LiEdward S. LuKenny KwanKwong-Kwok WongRosemarie SchmandtKaren H. LuSamuel C. MokNature PortfolioarticleScienceQENNature Communications, Vol 7, Iss 1, Pp 1-14 (2016)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Chi Lam Au Yeung
Ngai-Na Co
Tetsushi Tsuruga
Tsz-Lun Yeung
Suet-Ying Kwan
Cecilia S. Leung
Yong Li
Edward S. Lu
Kenny Kwan
Kwong-Kwok Wong
Rosemarie Schmandt
Karen H. Lu
Samuel C. Mok
Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
description The tumor microenviroment can influence cancer progression and response to therapy. In this study, the authors show that miR21 is transferred through exosomes from cancer-associated fibroblasts and adipocytes to ovarian cancer cells where it modulates drug resistance by its direct target APAF1.
format article
author Chi Lam Au Yeung
Ngai-Na Co
Tetsushi Tsuruga
Tsz-Lun Yeung
Suet-Ying Kwan
Cecilia S. Leung
Yong Li
Edward S. Lu
Kenny Kwan
Kwong-Kwok Wong
Rosemarie Schmandt
Karen H. Lu
Samuel C. Mok
author_facet Chi Lam Au Yeung
Ngai-Na Co
Tetsushi Tsuruga
Tsz-Lun Yeung
Suet-Ying Kwan
Cecilia S. Leung
Yong Li
Edward S. Lu
Kenny Kwan
Kwong-Kwok Wong
Rosemarie Schmandt
Karen H. Lu
Samuel C. Mok
author_sort Chi Lam Au Yeung
title Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
title_short Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
title_full Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
title_fullStr Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
title_full_unstemmed Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
title_sort exosomal transfer of stroma-derived mir21 confers paclitaxel resistance in ovarian cancer cells through targeting apaf1
publisher Nature Portfolio
publishDate 2016
url https://doaj.org/article/ff39043eef974cb8bf3b0f0a415eb6b1
work_keys_str_mv AT chilamauyeung exosomaltransferofstromaderivedmir21conferspaclitaxelresistanceinovariancancercellsthroughtargetingapaf1
AT ngainaco exosomaltransferofstromaderivedmir21conferspaclitaxelresistanceinovariancancercellsthroughtargetingapaf1
AT tetsushitsuruga exosomaltransferofstromaderivedmir21conferspaclitaxelresistanceinovariancancercellsthroughtargetingapaf1
AT tszlunyeung exosomaltransferofstromaderivedmir21conferspaclitaxelresistanceinovariancancercellsthroughtargetingapaf1
AT suetyingkwan exosomaltransferofstromaderivedmir21conferspaclitaxelresistanceinovariancancercellsthroughtargetingapaf1
AT ceciliasleung exosomaltransferofstromaderivedmir21conferspaclitaxelresistanceinovariancancercellsthroughtargetingapaf1
AT yongli exosomaltransferofstromaderivedmir21conferspaclitaxelresistanceinovariancancercellsthroughtargetingapaf1
AT edwardslu exosomaltransferofstromaderivedmir21conferspaclitaxelresistanceinovariancancercellsthroughtargetingapaf1
AT kennykwan exosomaltransferofstromaderivedmir21conferspaclitaxelresistanceinovariancancercellsthroughtargetingapaf1
AT kwongkwokwong exosomaltransferofstromaderivedmir21conferspaclitaxelresistanceinovariancancercellsthroughtargetingapaf1
AT rosemarieschmandt exosomaltransferofstromaderivedmir21conferspaclitaxelresistanceinovariancancercellsthroughtargetingapaf1
AT karenhlu exosomaltransferofstromaderivedmir21conferspaclitaxelresistanceinovariancancercellsthroughtargetingapaf1
AT samuelcmok exosomaltransferofstromaderivedmir21conferspaclitaxelresistanceinovariancancercellsthroughtargetingapaf1
_version_ 1718386757687312384